Roth Capital Downgrades Aeolus Pharmaceuticals (AOLS) to Neutral
Tweet
Share
E-mailGet Alerts AOLS Hot Sheet
Price: $0.00 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Roth Capital downgraded Aeolus Pharmaceuticals (OTCBB: AOLS) from Buy to Neutral with a price target of $1.00 (from $3.00).
For an analyst ratings summary and ratings history on Aeolus Pharmaceuticals click here. For more ratings news on Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.30 yesterday.
For an analyst ratings summary and ratings history on Aeolus Pharmaceuticals click here. For more ratings news on Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
- Canaccord Downgrades Quebecor (QBR/B-CN) (QBCRF) to Hold
- Citi Downgrades Pepsico (PEP) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
